AC
LLY icon

Argentiere Capital’s Eli Lilly LLY Stock Holding History

Argentiere Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-31,465
Closed -$2.43M – 71
2018
Q1 		$2.43M Buy
31,465
+18,308
+139% +$1.47M 1.04% 25
2017
Q4 		$1.11M Buy
+13,157
New +$1.12M 0.68% 23
2016
Q2 		– Sell
-18,390
Closed -$1.32M – 72
2016
Q1 		$1.32M Buy
18,390
+5,490
+43% +$415K 0.77% 20
2015
Q4 		$1.09M Buy
+12,900
New +$1.07M 0.5% 22

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Argentiere Capital's LLY Position: Q2 2018 in Review

Argentiere Capital sold out of Eli Lilly (LLY) in Q2 2018, closing a stake of 31,465 shares — an estimated $2.43M sold.

Argentiere Capital first reported a position in LLY in Q4 2015 and held it in 4 quarters. The position peaked at $2.43M in Q1 2018. 1,369 funds tracked by Wall St. Rank hold LLY as of Q2 2018.

  • Argentiere Capital reported no remaining Eli Lilly position as of Q2 2018 after selling out during the quarter.
  • Argentiere Capital sold 31,465 Eli Lilly shares in Q2 2018, an estimated $2.43M.
  • Argentiere Capital first reported a position in Eli Lilly in Q4 2015 and held it in 4 quarters.
  • Argentiere Capital's Eli Lilly position peaked at $2.43M in Q1 2018.
  • 1,369 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2018.

Based on Argentiere Capital's 13F filing for Q2 2018, filed 14 Aug 2018.